From: Effect of omega-3 polyunsaturated fatty acids on the cytoskeleton: an open-label intervention study
Parameters | t0 | t12 |
---|---|---|
Age [years] | 43.33 ± 4.40 | |
Height [cm] | 183.04 ± 1.32 | |
Weight [kg] | 87.88 ± 10.60 | 89.25 ± 10.92 |
Body mass index [kg/m2] | 26.17 ± 2.31 | 26.57 ± 2.37 |
Waist circumference [cm] | 92.25 ± 8.31 | 93.67 ± 10.15 |
Hip circumference [cm] | 102.17 ± 6.34 | 103.50 ± 7.30 |
Lipid levels | ||
Total cholesterol [mg/dl] | 217.42 ± 59.14 | 226.33 ± 53.44 |
Triacylglycerol [mg/dl] | 146.25 ± 63.37 | 109.92 ± 32.88a) |
High-density lipoprotein cholesterol [mg/dl] | 52.00 ± 11.35 | 54.33 ± 8.48 |
Low-density lipoprotein cholesterol [mg/dl] | 144.83 ± 50.49 | 155.33 ± 46.37 |
LDL/HDL ratio | 2.91 ± 1.09 | 2.94 ± 1.06 |
Fatty acids | ||
Omega-6 series: | ||
Dihomo-γ-linolenic acid (20:3 n6) [% of total fatty acids] | 2.04 ± 0.56 | 1.44 ± 0.34a) |
Arachidonic acid (20:4 n6) [% of total fatty acids] | 15.62 ± 0.87 | 12.26 ± 1.46a) |
Adrenic acid (22:4 n6) [% of total fatty acids] | 3.21 ± 0.56 | 1.88 ± 0.35a) |
Docosapentaenoic acid (22:5 n6) [% of total fatty acids] | 0.72 ± 0.11 | 0.45 ± 0.08a) |
Omega-3 series: | ||
Eicosapentaenoic acid (22:5 n3) [% of total fatty acids] | 0.92 ± 0.21 | 3.76 ± 0.84a) |
Docosapentaenoic acid (20:5 n3) [% of total fatty acids] | 2.92 ± 0.20 | 3.67 ± 0.43a) |
Docosahexaenoic acid (22:6 n3) [% of total fatty acids] | 4.83 ± 1.20 | 7.15 ± 0.79a) |
Omega-3 index [% of total fatty acids] | 5.74 ± 1.37 | 10.91 ± 1.53a) |